This Special Issue of *Epilepsia Open* presents the preclinical common data elements (CDEs) for epilepsy research studies that were generated by the TASK3 group of the International League Against Epilepsy/American Epilepsy Society (ILAE/AES) Joint Translational Task Force. Due to the importance of this work for the epilepsy research community, *Epilepsia Open* ^®^ implemented a more intense peer review process inviting 4‐8 expert reviewers to comment and review each companion paper and its associated CDEs and case report forms (CRFs). The reviewers were selected based on their expertise in the respective topic and were either recommended by the authors as experts and/or invited by the editors handling the manuscript based on their expertise and absence of relevant conflicts or interests. Reviewers were provided with a document (see Box [1](#epi412257-fea-0001){ref-type="boxed-text"}) highlighting the areas where special feedback was sought and were requested to offer their objective opinion on the quality of the work being reviewed.

###### Review of the preclinical CDE and CRFs for epilepsy: considerations for the reviewers.

 {#epi412257-sec-0002}

We appreciate your willingness to review the preclinical CDEs and CRFs created by the TASK3 group of the ILAE/AES Joint Translational Task Force. We offer you some examples of the type of feedback that would be particularly useful to the group when they revise these forms.

1CDE charts:(a)Please comment on the *type of data elements* included in each module and whether these encompass the CDEs that are thought of as important for the relevant studies.(b)Priority level for CDE: In many CDE charts, more CDEs have been included to provide options for the investigators who plan to use them. It is possible that some of these CDEs may not be necessary or relevant for some of the experiments designed by different investigators and, in such cases, these have been assigned with different levels of priority (high, moderate, optional). Please comment on whether you agree with the priority setting assigned for the specific CDEs you review or if you would recommend changing to a different level of priority (high, moderate, optional).(c)Permissible values and recommended settings: Please comment on whether they are appropriate as stated.(d)Data type, quantifiers, and input restrictions: Please comment on whether these are appropriate for the CDE.(e)Instructions: please comment on whether forms offer sufficient guidance to the person who will be using the CDEs to respond to the *question text* asked.(f)Population: It describes the age population for which the specific CDEs for each test is relevant for. Please comment on appropriateness of the designated population.2CRFs: Considering that these forms are meant to be used by investigators for data logging, please comment on their usefulness or suggest edits3Companion paper: These reports are planned to help the reader with the use of the CDEs and CRFs. Please comment on their accuracy or suggest any edits you may propose to the authors.

We truly appreciate the willingness and substantial contributions of the invited reviewers who dedicated a significant amount of effort in reviewing these documents. We list their names in this editorial in appreciation and recognition of their contribution in improving the quality of these papers, through their detailed and comprehensive critiques. We also wish to acknowledge and thank the submitting authors for their patience, responsibility, and meticulousness in addressing point by point each of these comments, so as to render the final products of their work more consistent with the feedback received by the external reviewers.

These preclinical CDEs are intended as tools for interested preclinical epilepsy investigators, to facilitate and promote collaborations, across studies' comparisons, utilization of big databases, and also improve consistence and quality of reporting of preclinical epilepsy research studies. The TASK3 group recognizes the importance of rendering these forms more user friendly and reflecting research practices that are accepted by the epilepsy research community. Therefore, the TASK3 group of the ILAE/AES Joint Translational Task Force and *Epilepsia Open* wish to open these documents to community feedback. Investigators who are involved in preclinical epilepsy research and wish to offer constructive comments that will improve the usability of these forms may send their feedback to Deborah Flower at <dflower@ilae.org> who in turn will post these comments at the ILAE website and forward them to the TASK3 group of the ILAE/AES Joint Translational Task Force for consideration and possible revision and update of these CDEs.
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